drugset / Trial / NCT01465282
Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the effectiveness of 3 dose strengths of CT327 ointment (0.05%, 0.1% and 0.05% w/w) compared to a placebo, when applied twice daily for up to 8 weeks, to the psoriatic plaques of patients with psoriasis vulgaris.
Timeline
- Start
- 2011-12
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CT327 | Unknown | 0.05 % | — |
| Subject | CT327 | Unknown | 0.1 % | — |
| Subject | CT327 | Unknown | 0.5 % | — |